Helios 计划 2027 年初向长寿诊所销售蛋白质组学血液检测,单次 $250–$600
AI 血液检测要进诊所卖钱了,一次 250 到 600 美元,还能告诉你心脏肝肾状态和该补什么。相比普通体检报告,它直接给干预建议。关注健康管理、预防医学创业的人可以看看这个定价和渠道打法。
据 The Information 独家报道,Helios 计划在 2027 年初开始向长寿诊所和私人医生(concierge doctors)销售其蛋白质组学血液检测产品,定价为每次 250 至 600 美元。
其 AI 模型会基于血液蛋白质组数据,估算心脏、肝脏、大脑和肾脏等器官的功能状态,并据此给出饮食、补充剂或药物调整建议。
这一模式把 AI 健康评估嵌入长寿诊所和高端私人医疗渠道,属于 AI 蛋白质组学检测商业化的具体落地:面向愿意为个性化健康管理付费的消费医疗市场,而非医院临床诊断路径。
Exclusive: Helios plans to start selling its proteomics blood test to longevity clinics and concierge doctors in early 2027, at $250 to $600 per test.
Its AI models estimate how the heart, liver, brain and kidneys are functioning, then recommend diet, supplement or medication changes.
Full story: https://thein.fo/4l0bfZm
This report is categorized under AITOP's "Products" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Within our cross-regional analytical framework, it directly maps to AI developer toolchains, coding agents, and engineering workflows. Key entities and technical topics under continuous tracking include Helios, proteomics.
Source attribution: curated from The Information (@theinformation).